drug
LUMISIGHT
updated 4mo agoby LUMICELL
community read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 1, 2030
~4.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Sep 14, 2034compositionUS 9763577
- Dec 8, 2031method-of-use (U-3890)US 10285759
- Dec 8, 2031method-of-use (U-3890)US 9032965
- Dec 8, 2031method-of-use (U-3890)US 9532835
- Oct 12, 2031method-of-use (U-3890)US 9155471
- Sep 1, 2030compositionUS 115923964.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that